Elevance Health, Inc. $ELV Position Boosted by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. lifted its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 126.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 350,519 shares of the company’s stock after purchasing an additional 195,659 shares during the period. Northwestern Mutual Wealth Management Co. owned about 0.16% of Elevance Health worth $122,874,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in Elevance Health by 0.6% in the third quarter. Vanguard Group Inc. now owns 22,998,645 shares of the company’s stock worth $7,431,322,000 after acquiring an additional 141,747 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Elevance Health by 4.8% in the third quarter. Wellington Management Group LLP now owns 6,621,297 shares of the company’s stock valued at $2,139,473,000 after purchasing an additional 303,099 shares during the period. Artisan Partners Limited Partnership increased its stake in shares of Elevance Health by 24.5% during the third quarter. Artisan Partners Limited Partnership now owns 4,576,805 shares of the company’s stock valued at $1,478,857,000 after acquiring an additional 901,626 shares during the period. First Eagle Investment Management LLC increased its stake in shares of Elevance Health by 0.6% during the fourth quarter. First Eagle Investment Management LLC now owns 4,022,874 shares of the company’s stock valued at $1,410,219,000 after acquiring an additional 24,271 shares during the period. Finally, Invesco Ltd. increased its stake in shares of Elevance Health by 22.9% during the third quarter. Invesco Ltd. now owns 2,597,488 shares of the company’s stock valued at $839,300,000 after acquiring an additional 484,303 shares during the period. Institutional investors own 89.24% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Truist Financial decreased their price target on shares of Elevance Health from $390.00 to $375.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Guggenheim raised their price objective on shares of Elevance Health from $396.00 to $399.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Citigroup raised shares of Elevance Health to a “buy” rating in a research note on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Elevance Health from $332.00 to $363.00 and gave the stock a “hold” rating in a research note on Thursday, April 23rd. Finally, Mizuho decreased their price objective on shares of Elevance Health from $413.00 to $350.00 and set an “outperform” rating for the company in a research note on Wednesday, March 11th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, Elevance Health has an average rating of “Moderate Buy” and an average price target of $384.58.

Elevance Health Trading Down 1.0%

Elevance Health stock opened at $392.74 on Friday. The company has a 50 day moving average price of $322.88 and a 200 day moving average price of $334.02. Elevance Health, Inc. has a 52 week low of $273.71 and a 52 week high of $412.96. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48. The firm has a market capitalization of $85.29 billion, a price-to-earnings ratio of 16.71, a P/E/G ratio of 2.23 and a beta of 0.66.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. The firm had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. The company’s revenue was up 1.5% on a year-over-year basis. During the same quarter last year, the business posted $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Research analysts forecast that Elevance Health, Inc. will post 26.79 EPS for the current year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be paid a dividend of $1.72 per share. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.8%. Elevance Health’s dividend payout ratio (DPR) is 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.